Recent General Skin Cancer News

Sonidegib Demonstrates Benefit in Advanced Basal Cell Skin Cancer in Phase II Trial (June 13, 2014)

An experimental drug sonidegib (LDE225) appears to markedly shrink tumors in patients with advanced basal cell carcinoma according to results recently presented at the 2014 annual meeting of the American... Continue Reading

Surgery May Not Be Best in Elderly Patients with Nonfatal Skin Cancer (June 28, 2013)

Although skin cancer is often treated with surgery, older patients with a limited life expectancy may not benefit from this treatment approach because they may endure complications and not live long enough... Continue Reading

Some Squamous Cell Skin Cancers Are Deadly (June 19, 2013)

Cutaneous squamous cell carcinoma is usually easily treated with surgery; however, a subsection of patients with specific disease risk factors are more likely to develop metastases and die from the disease,... Continue Reading

Coffee Might Reduce the Risk of Basal Cell Carcinoma (July 11, 2012)

Good news for coffee lovers—drinking caffeinated coffee could lower the risk of developing basal cell carcinoma, according to the results of a study published in Cancer Research. The Harvard study found... Continue Reading

Erivedge Effective in Basal-Cell Carcinoma (June 21, 2012)

The targeted agent Erivedge™ (vismodegib) is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma and may even reduce the rate of new basal-cell carcinomas,... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading

Erivedge Approved for Basal Cell Skin Cancer (February 1, 2012)

The US Food and Drug Administration (FDA) has approved the targeted therapy Erivedge™ (vismodegib) for the treatment basal cell carcinoma of the skin that has spread to other parts of the body or that... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (November 29, 2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results... Continue Reading

Additional Evidence That Tanning Beds Increase Skin Cancer Risk (November 3, 2011)

According to a study of more than 73,000 women, use of tanning beds increases the risk of three common types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. These results were... Continue Reading

Vismodegib Shrinks Advanced Basal Cell Skin Cancers (October 6, 2011)

The investigational targeted therapy vismodegib (GDC-0449) may provide a significant benefit to patients with locally advanced or metastatic basal cell skin cancers. The results of this Phase II clinical... Continue Reading

Next Page »